JOINT FILING AGREEMENT
Exhibit 99.1
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the undersigned agree to the joint filing on behalf of each of them
of a statement on Schedule 13G and/or 13D (including any and all amendments thereto) with respect to Common Stock, par value $0.0001 per share, of NeuBase Therapeutics, Inc., and further agree that this Joint Filing Agreement shall be included as
an Exhibit to such joint filings.
The undersigned further agree that each party hereto is responsible for the timely filing of such Statement on Schedule 13G and/or 13D
and any amendments thereto, and for the accuracy and completeness of the information concerning such party contained therein; provided, however, that no party is responsible for the accuracy or completeness of the information concerning any other
party, unless such party knows or has reason to believe that such information is inaccurate.
This Joint Filing Agreement may be signed in counterparts with the same effect as if the signature on each counterpart were upon the
same instrument.
IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the date written below.
Date: July 16,
2019
|
GREENLIGHT CAPITAL, INC.
|
|
|
By: /s/ XXXXXX XXXXXXX
|
|
|
Xxxxxx Xxxxxxx
Chief Operating Officer
|
|
|
DME CAPITAL MANAGEMENT, LP
|
|
|
By: DME Advisors GP, LLC,
|
|
|
its General Partner
|
|
|
By: /s/ XXXXXX XXXXXXX
|
|
|
Xxxxxx Xxxxxxx
Chief Operating Officer
|
|
|
DME ADVISORS GP, LLC
|
|
|
By: /s/ XXXXXX XXXXXXX
|
|
|
Xxxxxx Xxxxxxx
Chief Operating Officer
|
|
|
/s/ XXXXXX XXXXXXX*
|
|
|
Xxxxxx Xxxxxxx, on behalf of Xxxxx Xxxxxxx
|
* The Power of Attorney executed by Xxxxx Xxxxxxx, authorizing the signatory to sign and file this Schedule 13G on Xxxxx Xxxxxxx’x
behalf, filed as Exhibit 99.2 to the Schedule 13G filed with the Securities and Exchange Commission on May 24, 2010 by the Reporting Persons with respect to the common stock of XXX Xxxxxxxxxxx, is hereby incorporated by reference.
